Xvivo Perfusion AB (OSTO:XVIVO) Total Equity

: kr1,945.0 Mil (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

Xvivo Perfusion AB's total equity for the quarter that ended in Dec. 2023 was kr1,945.0 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Xvivo Perfusion AB Total Equity Historical Data

The historical data trend for Xvivo Perfusion AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xvivo Perfusion AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Equity

Get a 7-Day Free Trial

577.52

1,008.46

1,285.45

1,430.14

1,945.05

Xvivo Perfusion AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Equity	Get a 7-Day Free Trial															1,430.14	1,446.88	1,503.35	1,928.12	1,945.05

Xvivo Perfusion AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Xvivo Perfusion AB's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	2195.611	-	250.566
	=	1,945.0

Xvivo Perfusion AB's Total Equity for the quarter that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	2195.611	-	250.566
	=	1,945.0

Xvivo Perfusion AB Total Equity Related Terms

Thank you for viewing the detailed overview of Xvivo Perfusion AB's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Xvivo Perfusion AB (OSTO:XVIVO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xvivo Perfusion AB (OSTO:XVIVO) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

XVIPF:USA 3XV:Germany

Address

Massans gata 10, P.O. Box 53015, Gothenburg, SWE, SE-400 14

Website

https://www.xvivoperfusion.com

Xvivo Perfusion AB is a medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments namely, Thoracic: Sales of lung and heart transplant products, Abdominal: Sales of liver and kidney transplant products. Services: Revenue from sales of services in organ recovery (carried out by subsidiary STAR Teams Inc.). The majority of revenue is derived from the Thoracic segment. Geographically, the majority is from the United States.

Xvivo Perfusion AB (OSTO:XVIVO) Headlines

No Headlines